-

Dexcom, Nick Jonas, Patti LaBelle and The Global Movement for Time in Range Invite the World to #SeeDiabetes This November

  • During National Diabetes Awareness Month and World Diabetes Day, people with diabetes and their support systems around the globe band together to help the diabetes community feel more seen and heard
  • Global activities, including a virtual Congressional testimony from Patti LaBelle, will advocate for improved access to diabetes care
  • Join the conversation with #SeeDiabetes and visit WhenInRange.com for more information

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, its nonprofit partners and members of the diabetes community are banding together to help people with diabetes feel more seen and heard this November for National Diabetes Awareness Month and World Diabetes Day.

The Global Movement for Time in Range, an initiative launched earlier this year to accelerate the adoption of time in range as an important metric in diabetes management, will help the world #SeeDiabetes through activities that raise awareness about healthcare disparities and the need for greater global access to diabetes technology that can measure time in range.

Aligned with the theme for World Diabetes Day 2021-23, 'Access to Diabetes Care,' Dexcom and The Global Movement will enlist some star power to drive forward the important conversation about access to healthcare and show decisionmakers that all people with diabetes deserve to feel their best.

Stars with Diabetes Make Their Voices—and the Voices of Others—Heard

To kick off the activities, multi-platinum recording artist, actor and philanthropist, Nick Jonas, will use his platform for the entire month of November to help the world truly #SeeDiabetes by featuring the stories of people around the world living with diabetes on his Instagram channel. From Nov. 1 through Nov. 30, Jonas will share a new Instagram Story each day with his 31.5 million followers to increase awareness for what it is like to live with diabetes and to highlight the inspiring ways people are managing the disease and still accomplishing their dreams.

Then, on Nov. 4, legendary GRAMMY-winning artist, actress, author and entrepreneur, Patti LaBelle, will join the Diabetes Leadership Council to speak to Congress during a virtual event with The Hill. Ms. LaBelle will speak about her experience living with diabetes and advocate for better access to care for people with Type 2 diabetes, especially in communities of color.

“As someone who’s lived with Type 2 diabetes for over 25 years, I've seen and benefitted from advances in technology like the Dexcom G6 CGM System,” says Ms. LaBelle. “But to know that so many people—especially in Black communities where diabetes is more prevalent—don't have access to this life-changing technology is simply not okay. Diabetes is often invisible to everyone except those living with it—so we need to make it visible and help people access the care and technology they deserve.”

To watch The Hill event on Thursday, Nov. 4 at 9 a.m. PDT / 12 p.m. EDT, register HERE.

To amplify this important conversation worldwide, prominent members of the diabetes community around the globe will help people with diabetes feel seen and heard wherever they live—including the UK’s Ed Gamble, comedian (diagnosed in 1999); Germany’s Matthias Steiner, Olympic, World and European weightlifting champion (diagnosed in 2000); and Australia’s Stephanie “Bambi” Northwood-Blyth (diagnosed in 2002).

Going Beyond Time in Range

Earlier this year, The Global Movement for Time in Range released results from a survey of people with insulin-treated diabetes to start a conversation about the importance of time in range. That survey found that the vast majority (84%) of people with insulin-treated diabetes believe they deserve the most cutting-edge technology available to manage their disease1, yet many are still unable to access CGM technology, which will continue to be a barrier in helping more people with diabetes adopt the time in range metric. While significant progress has been made to improve access to CGM, which is covered in the United States in some form by 99% of private insurance, Medicare and Medicaid in 40 states, more can be done to broaden coverage as well as existing coverage criteria.

“The Global Movement for Time in Range is about helping people with diabetes feel their best—and that typically happens through access to the best care and technologies,” said Thom Scher, chief executive officer of Beyond Type 1, an organization Nick Jonas co-founded and a member of The Global Movement for Time in Range. “When we formed this initiative earlier this year, we recognized that it’s not enough to educate others on time in range, but we also need to advocate for access to the devices that are going to help people with diabetes adopt this important metric.”

To get involved in the conversation and help people with diabetes feel seen and heard, share pictures on social media of a loved one with diabetes, yourself, or your support network using the hashtag #SeeDiabetes.

About The Global Movement for Time in Range

The Global Movement for Time in Range is a global consortium of diabetes community thought leaders working together to improve the understanding and accelerate the adoption of time in range as an important metric to support diabetes management. With the support of Nick Jonas, Beyond Type 1, Children with Diabetes, College Diabetes Network, Dexcom, JDRF International and Taking Control of Your Diabetes, the group will jointly address issues to improve the lives of people with diabetes. To learn more about the movement and how to get involved, visit WhenInRange.com.

1 Dexcom, US data on file, November 2020

Contacts

Media Contact
James McIntosh
619-884-2118
james.mcintosh@dexcom.com

Investor Contact
Sean Christensen
858-203-6657
sean.christensen@dexcom.com

Dexcom, Inc.

NASDAQ:DXCM

Release Summary
DEXCOM, NICK JONAS, PATTI LABELLE AND THE GLOBAL MOVEMENT FOR TIME IN RANGE INVITE THE WORLD TO #SEEDIABETES THIS NOVEMBER
Release Versions
$Cashtags

Contacts

Media Contact
James McIntosh
619-884-2118
james.mcintosh@dexcom.com

Investor Contact
Sean Christensen
858-203-6657
sean.christensen@dexcom.com

More News From Dexcom, Inc.

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clinically and statistically significant reduction in A1C and improvement in glucose control among people with Type 2 diabetes not using insulin compared with a routine care control group using self-monitoring of blood glucose.1 Researchers presented these results today as an oral presentation at the 2026 Scientific Sessions of...

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) will present new clinical findings, product advancements and strategic business initiatives reinforcing its commitment to improving care for people with all types of diabetes and ushering in a new era of early stage CGM intervention and preventative care at the American Diabetes Association’s Scientific Sessions in New Orleans, June 5-8, 2026. “Dexcom has built a legacy of innovation within the diabetes space and as we look to the future, e...

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc., the global leader in glucose biosensing, today released its inaugural Customer Advisory Council Report, detailing candid feedback from users, caregivers, healthcare professionals and community leaders, along with clear, actionable company commitments to further elevate product performance and user experience. Building on its position as the manufacturer of the most accurate CGM systems1, Dexcom continues to listen, innovate and act on customer insights...
Back to Newsroom